Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Cash Flows (Unaudited)

v3.24.1.1.u2
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2024
Mar. 31, 2023
Cash flows from operating activities:        
Net loss $ (1,653,542) $ (2,797,971) $ (6,851,734) $ (9,236,758)
Adjustments to reconcile net loss to net cash used in operating activities        
Stock-based compensation 200,000 200,000 581,698 661,158
Amortization of loan commitment fee     91,534
Changes in operating assets and liabilities:        
Prepaid expenses     199,072 763,159
Accounts payable     (149,625) 190,074
Accrued expenses     91,145 788,480
Net cash used in operating activities     (6,037,910) (6,833,887)
Cash flows from financing activities:        
Proceeds from issuance of common stock     6,646,748
Payment of financing/offering costs     (62,354) (248,927)
Proceeds from issuance of common stock upon exercise of options     52,400
Net cash (used in) provided by financing activities     (62,354) 6,450,221
Net decrease in cash     (6,100,264) (383,666)
Cash, beginning of period     11,247,403 14,548,471
Cash, end of the period $ 5,147,139 $ 14,164,805 5,147,139 14,164,805
Noncash investing and financing activities:        
Financing commitment fee funded through issuance of common stock     $ 654,000